Fenwick & West represented Umoja Biopharma in the transaction. Umoja Biopharma, Inc., a developer of in vivo cell therapies that aim to realize the full reach...
Umoja Biopharma’s $100 Million Series C Financing Round
BILL’s $1.4 Billion Convertible Senior Notes Offering
Fenwick & West represented BILL Holdings, Inc. in the offering, and Wilson Sonsini Goodrich & Rosati represented the initial purchasers. BILL Holdings, Inc. (NYSE: BILL), a...

























